NCI report: Number of US cancer survivors increases to 11.7 million during 2007

NewsGuard 100/100 Score

The number of cancer survivors in the United States increased to 11.7 million in 2007, according to a report released by the Centers for Disease Control and Prevention and the National Cancer Institute (NCI), part of the National Institutes of Health. There were 3 million cancer survivors in 1971 and 9.8 million in 2001.

A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life.

The study, "Cancer Survivors in the United States, 2007," is published today in the CDC's Morbidity and Mortality Weekly Report.

"It's good news that so many are surviving cancer and leading long, productive, and healthy lives," said CDC Director Thomas R. Frieden, M.D., M.P.H.  "Preventing cancer and detecting it early remain critically important as some cancers can be prevented or detected early enough to be effectively treated.  Not smoking, getting regular physical activity, eating healthy foods, and limiting alcohol use can reduce the risk of many cancers."

To determine the number of survivors, the authors analyzed the number of new cases and follow-up data from NCI's Surveillance, Epidemiology and End Results Program between 1971 and 2007. Population data from the 2006 and 2007 United States Census were also included. The researchers estimated the number of persons ever diagnosed with cancer who were alive on Jan. 1, 2007 (except non-melanoma skin cancers, which are fairly common and rarely fatal).

Study findings indicate:

  • Of the 11.7 million people living with cancer in 2007, 7 million were ages 65 years or older.
  • Women make up a large proportion of cancer survivors (54 percent).
  • Breast cancer survivors are the largest group of cancer survivors (22 percent), followed by prostate cancer survivors (19 percent) and colorectal cancer survivors (10 percent).
  • Among all survivors, 4.7 million received their diagnosis 10 or more years earlier.

"As the number of cancer survivors continues to increase, it is important for medical and public health professionals to be knowledgeable of issues survivors may face, especially the long-term effects of treatment on their physical and psychosocial well-being," said Arica White, Ph.D., M.P.H., an epidemic intelligence service officer in CDC's Division of Cancer Prevention and Control. "This understanding is critical in promoting good health and coordinating comprehensive care for cancer survivors."

The authors note that the increase in number of cancer survivors is due to many factors, including a growing aging population, early detection, improved diagnostic methods, more effective treatment, and improved clinical follow-up after treatment.

"There is now a growing number of people who have faced a cancer diagnosis which affects them and their loved ones – from the time of diagnosis through the rest of their lives," said Julia H. Rowland, Ph.D., director of NCI's Office of Cancer Survivorship. "Unfortunately for many cancer survivors and those around them, the effect of cancer does not end with the last treatment.  Research has allowed us to scratch the surface of understanding the unique risks, issues, and concerns of this population. This report underscores the need for continued research, as well as for the development and implementation of best practices to provide optimal care and support for all cancer survivors."

SOURCE Centers for Disease Control and Prevention (CDC)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels